Letter: Cancer patients need a patient-centred and fit for purpose pharmaceutical system | Association of European Cancer Leagues - ECL

Cancer Prevention
Access To Medicines
Patient Support
- Patient Support Working Group
MEPs Against Cancer
Other Areas

Cancer Prevention
Access To Medicines
Patient Support
- Patient Support Working Group
MEPs Against Cancer
Other Areas

2023-03-16_ECL-Anticancer-Fund-EFPN-letter-to-the-European-Commission_Revision-of-the-EU-pharmaceuticals-legislation-1

About the author

Ivonne

Leave a Reply Cancel Reply

You must be logged in to post a comment.

Contact us
Main office:
Chaussée de Louvain 479
1030 Brussels
Belgium

EU Office:
Rue de l’Industrie 10
1000 Brussels
Belgium

Press inquiries
ivonne@cancer.eu

Transparency
register
number
19265592757-25